272 related articles for article (PubMed ID: 19369342)
1. Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway.
Gould F; Harrison SM; Hewitt EW; Whitehouse A
J Virol; 2009 Jul; 83(13):6727-38. PubMed ID: 19369342
[TBL] [Abstract][Full Text] [Related]
2. KSHV RTA Induces Degradation of the Host Transcription Repressor ID2 To Promote the Viral Lytic Cycle.
Combs LR; Spires LM; Alonso JD; Papp B; Toth Z
J Virol; 2022 Jun; 96(12):e0010122. PubMed ID: 35604218
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus transactivator RTA promotes degradation of the repressors to regulate viral lytic replication.
Yang Z; Yan Z; Wood C
J Virol; 2008 Apr; 82(7):3590-603. PubMed ID: 18216089
[TBL] [Abstract][Full Text] [Related]
4. NCOA2 promotes lytic reactivation of Kaposi's sarcoma-associated herpesvirus by enhancing the expression of the master switch protein RTA.
Wei X; Bai L; Dong L; Liu H; Xing P; Zhou Z; Wu S; Lan K
PLoS Pathog; 2019 Nov; 15(11):e1008160. PubMed ID: 31751430
[TBL] [Abstract][Full Text] [Related]
5. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
Li Q; He M; Zhou F; Ye F; Gao SJ
J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
Wakeman BS; Izumiya Y; Speck SH
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
[TBL] [Abstract][Full Text] [Related]
7. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
Yang Z; Wood C
J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation.
Izumiya Y; Kobayashi K; Kim KY; Pochampalli M; Izumiya C; Shevchenko B; Wang DH; Huerta SB; Martinez A; Campbell M; Kung HJ
PLoS Pathog; 2013; 9(8):e1003506. PubMed ID: 23990779
[TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
Wang SE; Wu FY; Yu Y; Hayward GS
J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
[TBL] [Abstract][Full Text] [Related]
10. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
[TBL] [Abstract][Full Text] [Related]
11. RNF213 modulates γ-herpesvirus infection and reactivation via targeting the viral Replication and Transcription Activator.
Tian H; Yu K; He L; Xu H; Han C; Zhang X; Wang X; Zhang X; Zhang L; Gao G; Deng H
Proc Natl Acad Sci U S A; 2023 Mar; 120(12):e2218825120. PubMed ID: 36917666
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Innate Immune DNA Sensor IFI16 Is Degraded during Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus (KSHV): Role of IFI16 in Maintenance of KSHV Latency.
Roy A; Dutta D; Iqbal J; Pisano G; Gjyshi O; Ansari MA; Kumar B; Chandran B
J Virol; 2016 Oct; 90(19):8822-41. PubMed ID: 27466416
[TBL] [Abstract][Full Text] [Related]
13. The Itch ubiquitin ligase is required for KSHV RTA induced vFLIP degradation.
Chmura JC; Herold K; Ruffin A; Atuobi T; Fabiyi Y; Mitchell AE; Choi YB; Ehrlich ES
Virology; 2017 Jan; 501():119-126. PubMed ID: 27912080
[TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus processivity factor (PF-8) recruits cellular E3 ubiquitin ligase CHFR to promote PARP1 degradation and lytic replication.
Chung WC; Lee S; Kim Y; Seo JB; Song MJ
PLoS Pathog; 2021 Jan; 17(1):e1009261. PubMed ID: 33508027
[TBL] [Abstract][Full Text] [Related]
15. KSHV RTA abolishes NFκB responsive gene expression during lytic reactivation by targeting vFLIP for degradation via the proteasome.
Ehrlich ES; Chmura JC; Smith JC; Kalu NN; Hayward GS
PLoS One; 2014; 9(3):e91359. PubMed ID: 24614587
[TBL] [Abstract][Full Text] [Related]
16. Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).
Ahmad H; Gubbels R; Ehlers E; Meyer F; Waterbury T; Lin R; Zhang L
J Biol Chem; 2011 Mar; 286(10):7865-7872. PubMed ID: 21212282
[TBL] [Abstract][Full Text] [Related]
17. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
Lan K; Kuppers DA; Verma SC; Robertson ES
J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
[TBL] [Abstract][Full Text] [Related]
18. KSHV RTA utilizes the host E3 ubiquitin ligase complex RNF20/40 to drive lytic reactivation.
Spires LM; Wind E; Papp B; Toth Z
J Virol; 2023 Nov; 97(11):e0138923. PubMed ID: 37888983
[TBL] [Abstract][Full Text] [Related]
19. Modulation of global SUMOylation by Kaposi's sarcoma-associated herpesvirus and its effects on viral gene expression.
Wang J; Guo Y; Wang X; Zhao R; Wang Y
J Med Virol; 2017 Nov; 89(11):2011-2019. PubMed ID: 28639696
[TBL] [Abstract][Full Text] [Related]
20. KSHV RTA induces a transcriptional repressor, HEY1 that represses rta promoter.
Yada K; Do E; Sakakibara S; Ohsaki E; Ito E; Watanabe S; Ueda K
Biochem Biophys Res Commun; 2006 Jun; 345(1):410-8. PubMed ID: 16678790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
